Stress-Induced Proteins in Immune Response to Cancer

1991 ◽  
pp. 109-123 ◽  
Author(s):  
R. K. Srivastava ◽  
R. G. Maki
Keyword(s):  
Immune Response ◽  
Immune Response To Cancer ◽  
Induced Proteins

scholarly journals Network Representation of T-Cell Repertoire— A Novel Tool to Analyze Immune Response to Cancer Formation

2018 ◽  
Vol 9 ◽  
Author(s):  
Avner Priel ◽  
Miri Gordin ◽  
Hagit Philip ◽  
Alona Zilberberg ◽  
Sol Efroni
Keyword(s):  
Immune Response ◽  
T Cell ◽  
T Cell Repertoire ◽  
Cell Repertoire ◽  
Network Representation ◽  
Immune Response To Cancer

Current Concepts of Tumor Immunology III. Immune Therapy

1978 ◽  
Vol 87 (1) ◽  
pp. 138-141 ◽  
Author(s):  
Charles J. Krause ◽  
John O. Nysather
Keyword(s):  
Immune Response ◽  
Radiation Therapy ◽  
Tumor Cells ◽  
Tumor Immunology ◽  
Normal Tissue ◽  
Immune Therapy ◽  
Great Promise ◽  
Adjacent Normal Tissue ◽  
Immune Response To Cancer ◽  
Treatment Surgery

It is apparent that development of consistently effective methods of immunotherapy must await a more thorough understanding of the immune response to cancer. However, even those forms of immunotherapy which have been developed to date indicate a tremendous potential. It appears that immunotherapy may be most useful as an adjuvant to established forms of treatment. Surgery, radiation therapy and/or chemotherapy are used to remove all of the gross tumor, with immune therapy then employed to destroy the small foci of tumor which remain. As methods are developed which are effective in counteracting the immunosuppression of tumors, other means of immunotherapy may be found which are capable of destroying tumor cells while not affecting the adjacent normal tissue. Thus, the future of immune therapy holds great promise. As more is learned about the immune response to cancer, advances in therapy will certainly follow.

CD4+T cells suppress immune response to cancer: novel targets for antitumor efforts

2012 ◽  
Vol 8 (5) ◽  
pp. 401-403 ◽  
Author(s):  
Allison Nelson ◽  
Sajitha Nair ◽  
Srinivas Nagaraj
Keyword(s):  
Immune Response ◽  
T Cells ◽  
Cd4 T Cells ◽  
Immune Response To Cancer ◽  
Novel Targets

scholarly journals Tumor suppressor maspin as a modulator of host immune response to cancer

2015 ◽  
Vol 15 (4) ◽  
Author(s):  
Sijana H. Dzinic ◽  
Maria M. Bernardo ◽  
Daniel S.M. Oliveira ◽  
Marian Wahba ◽  
Wael Sakr ◽  
...  
Keyword(s):  
Immune Response ◽  
Tumor Suppressor ◽  
Host Immune Response ◽  
Immune Response To Cancer

scholarly journals Synergistic Effects of Acoustics-based Therapy and Immunotherapy in Cancer Treatment

2021 ◽  
Author(s):  
Yuheng Bao ◽  
Jifan Chen ◽  
Pintong Huang ◽  
Weijun Tong
Keyword(s):  
Immune Response ◽  
Cancer Treatment ◽  
Cancer Immunotherapy ◽  
Synergistic Effects ◽  
Research Field ◽  
Cancer Tissue ◽  
Activated T Cells ◽  
Immunological Recognition ◽  
The Status ◽  
Immune Response To Cancer

Cancer is an intractable disease and has ability to escape immunological recognition. Cancer immunotherapy to enhance the autogenous immune response to cancer tissue is reported to be the most promising method for cancer treatment. After the release of damage-associated molecular patterns, dendritic cells come mature and then recruit activated T cells to induce immune response. To trigger the release of cancer associated antigens, cancer acoustics-based therapy has various prominent advantages and has been reported in various research. In this review, we classified the acoustics-based therapy into sonopyrolysis-, sonoporation-, and sonoluminescence-based therapy. Then, detailed mechanisms of these therapies are discussed to show the status of cancer immunotherapy induced by acoustics-based therapy in quo. Finally, we express some future prospects in this research field and make some predictions of its development direction

scholarly journals Overcoming the problem of the lack of an immune response to cancer: A possible haptogenic approach to cancer immunotherapy

2021 ◽  
Vol 5 (1) ◽  
pp. 01-04
Author(s):  
Patrick Riley
Keyword(s):  
Immune Response ◽  
Cancer Cells ◽  
Cancer Immunotherapy ◽  
Immunological Response ◽  
Gene Products ◽  
Malignant Cells ◽  
Deviant Behaviour ◽  
Anti Cancer ◽  
Immune Response To Cancer ◽  
Normal Gene

Cancer cells possess a number of unusual features, most of which are explicable in the light of the theory of epigenetic carcinogenesis. This includes the remarkable failure of malignant cells to evoke an immunological response from the host which is ascribed to their deviant behaviour resulting from anomalous expression of normal gene products. Given this background a possible approach to eliciting a specific anti-cancer immune response is proposed which involves selective haptenation of an identifiable target protein.

Sign in / Sign up

Export Citation Format

Share Document